Oscar Hinojosa, Nico-al Paolo Gotera, Jonathan Dao, Ariana N. Neely, Arshi Syal, Yajur Arya, Viral M. Patel, Colton Jones. "GLP-1 receptor agonists vs 5-alpha reductase inhibitors for prostate cancer primary prevention in high-risk men: A real-world head-to-head comparison.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e17134